Fig. 7: ILC subsets respond to HIV through cytokine secretion and surface receptor alterations.

a, Representative contour plot of CD4 expression in genital T cells, EM, END and ECT ILCs. b, Percentage of ILCs expressing CD4 for each tissue type across all patients (n = 60 tissues: EM, n = 24; END, n = 19; ECT, n = 19). c, Percentage of CD4+ ILC1s and ILC3s in each tissue (n = 60 tissues: EM, n = 24; END, n = 18; ECT, n = 19). d, Comparison of CD161 MFI between CD4+ and CD4− ILCs (n = 60 tissues). e, Representative image of a CD4+ ILC1 in the ECT. f, Representative contour plot of CD4 and CCR5 co-expression on ILCs (left) and quantification (right) (EM, n = 24; END, n = 24; ECT, n = 19). g, Histogram of IFNγ (top) and CD107a (bottom) expression in CD161+ and CD161− ILC1s. Quantification of intracellular IFNγ and CD107a in control and HIV-stimulated ILC1s (n = 9). The connecting line represents one patient. h, Contour plot showing CD4 and CD107a expression in control ILC1s and stimulated with HIV and gp120. Quantification of CD4+ ILC1s with and without HIV stimulation (right) (n = 10 tissues). i, Percentage of CD161− ILC1s that were CD4+ (left), IFNγ+ (middle) and CD107a+ before and after gp120 stimulation (n = 9 tissues) j, Histogram of IL-22 (top) and CD107a (bottom) expression in CD161+ and CD161− ILC3s. Quantification of intracellular IL-22 and CD107a in control and HIV-stimulated ILC3s (right). The connecting line represents one patient (n = 9). k, Contour plot representing CD161 and NKp44 expression on endometrial (top left) and ectocervical (bottom left) ILC3s stimulated with and without HIV. Percentage of CD161hi (top right) (n = 12 tissues) and NKp44+ (n = 6 tissues) (bottom right) ILC3s with HIV stimulation. l, Percentage of IL-22+ (top) and CD107a+ (bottom) CD161+ ILC3s with and without gp120 stimulation (n = 8 tissues). Each dot represents a biological replicate. Horizontal lines represent the median ± IQR. Statistical analysis was performed using the non-parametric Kruskal–Wallis test (two-sided) with Dunn’s post hoc test correction for multiple comparisons. Paired comparisons were done with the Wilcoxon non-parametric test (two-sided).